U.S. Markets open in 3 hrs 39 mins

Arena Pharmaceuticals, Inc. (ARNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
87.14+1.64 (+1.92%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.12
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 387.59
52 Week Low 332.95
50-Day Moving Average 375.58
200-Day Moving Average 364.32

Share Statistics

Avg Vol (3 month) 3586k
Avg Vol (10 day) 3738.23k
Shares Outstanding 557.65M
Float 57.56M
% Held by Insiders 10.15%
% Held by Institutions 184.16%
Shares Short (Oct 14, 2020) 43.62M
Short Ratio (Oct 14, 2020) 45.46
Short % of Float (Oct 14, 2020) 46.29%
Short % of Shares Outstanding (Oct 14, 2020) 46.28%
Shares Short (prior month Sep 14, 2020) 43.7M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jun 18, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)-7,926.83%

Management Effectiveness

Return on Assets (ttm)-17.42%
Return on Equity (ttm)-28.34%

Income Statement

Revenue (ttm)4.61M
Revenue Per Share (ttm)0.09
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)574.93M
EBITDA -362.14M
Net Income Avi to Common (ttm)-346.31M
Diluted EPS (ttm)-6.82
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.17B
Total Cash Per Share (mrq)20.31
Total Debt (mrq)59.34M
Total Debt/Equity (mrq)4.78
Current Ratio (mrq)28.75
Book Value Per Share (mrq)21.58

Cash Flow Statement

Operating Cash Flow (ttm)-285.64M
Levered Free Cash Flow (ttm)-174.16M